Kenya Stakeholders Consultation, November 7-9, 2022
MATRIX convened an in-country consultation with stakeholders in Nairobi, Kenya, November 8-9, 2022. Below are the documents and presentations from this meeting. Photos from both the consultation and a pre-meeting workshop (held 7 November) can be viewed here.
Description | Date | Size |
---|
About MATRIX Fact Sheet (Download) | 2022-11-03 | 748.64 KB |
Agenda (Download) | 2022-11-08 | 362.29 KB |
KENYA Stakeholder Consultation Summary and Key Comments (Download) | 2022-11-23 | 2.96 MB |
The Big Picture: The current and evolving HIV prevention landscape (Download) | 2022-11-08 | 1.41 MB |
MATRIX: Developing the next generation of HIV prevention products for women (Download) | 2022-11-08 | 2.18 MB |
Understanding the Research and Development Process (Download) | 2022-11-08 | 853.48 KB |
Conducting early phase and first-in-human studies in sub-Saharan Africa (Download) | 2022-11-08 | 559.3 KB |
Tenofovir Alafenamide / Elvitegravir Fast Dissolving Inserts (Download) | 2022-11-08 | 2.1 MB |
MATRIX-001 Phase 1 Study of the TAF/EVG Fast-Dissolving Insert (Download) | 2022-11-08 | 599.15 KB |
One-Month Dapivirine Vaginal Film (Download) | 2022-11-08 | 1.4 MB |
MATRIX-002 Acceptability and Safety Study of Two Prototype Vaginal Films (Download) | 2022-11-08 | 561.81 KB |
MATRIX Stakeholders Meeting Recap of Day One (Download) | 2022-11-09 | 705.87 KB |
Luminally Active Multipurpose Prevention Intravaginal Ring (LAMP-IVR) (Download) | 2022-11-09 | 11.23 MB |
Griffithsin Fast Dissolving Insert (GRFT FDI) (Download) | 2022-11-09 | 9.5 MB |
Cabotegravir Dissolvable Pellet Implants and Cabotegravir Injectable Depot (Download) | 2022-11-09 | 2.27 MB |